Shandong Sinoglory Health (603182) - Total Assets
Based on the latest financial reports, Shandong Sinoglory Health (603182) holds total assets worth CN¥1.39 Billion CNY (≈ $203.79 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Shandong Sinoglory Health (603182) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Shandong Sinoglory Health - Total Assets Trend (2020–2025)
This chart illustrates how Shandong Sinoglory Health's total assets have evolved over time, based on quarterly financial data. Check Shandong Sinoglory Health (603182) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Shandong Sinoglory Health - Asset Composition Analysis
Current Asset Composition (December 2025)
Shandong Sinoglory Health's total assets of CN¥1.39 Billion consist of 40.1% current assets and 59.9% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 6.8% |
| Accounts Receivable | CN¥96.10 Million | 7.0% |
| Inventory | CN¥247.55 Million | 18.0% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥101.56 Million | 7.4% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2020–2025)
This chart illustrates how Shandong Sinoglory Health's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Shandong Sinoglory Health (603182) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shandong Sinoglory Health's current assets represent 40.1% of total assets in 2025, a decrease from 43.6% in 2020.
- Cash Position: Cash and equivalents constituted 6.8% of total assets in 2025, down from 18.4% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, a decrease from 11.0% in 2020.
- Asset Diversification: The largest asset category is inventory at 18.0% of total assets.
Shandong Sinoglory Health Competitors by Total Assets
Key competitors of Shandong Sinoglory Health based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Nestle S.A.
SW:NESN
|
Switzerland | CHF127.15 Billion |
|
JBS N.V.
NYSE:JBS
|
USA | $248.34 Billion |
|
MEIJI HLD.UN.ADR 1/4 O.N.
F:3M00
|
Germany | €1.23 Trillion |
|
CSPC Innovation Pharmaceutical Co Ltd Class A
SHE:300765
|
China | CN¥6.21 Billion |
|
ORKLA ADR/1 NK 625
F:OKL0
|
Germany | €88.70 Billion |
|
Tingyi (Cayman Islands) Holding Corp
F:TYG
|
Germany | €54.94 Billion |
|
Yantai China Pet Foods Co Ltd
SHE:002891
|
China | CN¥6.24 Billion |
|
Yihai International Holding Ltd
F:YIR
|
Germany | €5.36 Billion |
Shandong Sinoglory Health - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.27 | 2.07 | 4.52 |
| Quick Ratio | 1.98 | 1.33 | 3.52 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥406.08 Million | CN¥304.91 Million | CN¥684.28 Million |
Shandong Sinoglory Health - Advanced Valuation Insights
This section examines the relationship between Shandong Sinoglory Health's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.82 |
| Latest Market Cap to Assets Ratio | 0.22 |
| Asset Growth Rate (YoY) | -4.0% |
| Total Assets | CN¥1.37 Billion |
| Market Capitalization | $298.82 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shandong Sinoglory Health's assets below their book value (0.22x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Shandong Sinoglory Health's assets decreased by 4.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Shandong Sinoglory Health (2020–2025)
The table below shows the annual total assets of Shandong Sinoglory Health from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.37 Billion ≈ $201.18 Million |
-4.00% |
| 2024-12-31 | CN¥1.43 Billion ≈ $209.56 Million |
+11.45% |
| 2023-12-31 | CN¥1.28 Billion ≈ $188.03 Million |
+8.58% |
| 2022-12-31 | CN¥1.18 Billion ≈ $173.18 Million |
+46.91% |
| 2021-12-31 | CN¥805.58 Million ≈ $117.88 Million |
+27.77% |
| 2020-12-31 | CN¥630.51 Million ≈ $92.26 Million |
-- |
About Shandong Sinoglory Health
Shandong Sinoglory Health Food Co., Ltd. manufactures soy proteins in China. The company offers soy protein isolate, concentrate, low-temperature edible soybean meal, soybean oil, and soy dietary fiber products. It also exports its products. The company serves in the United States, the European Union, and Australia. Shandong Sinoglory Health Food Co., Ltd. was founded in 2000 and is based in Liao… Read more